Genetic Variations and Addiction to Opioids and Methamphetamine in Iran
Author Information
Author(s): Eskandarion Mohammad Reza, Jafaripour Simin, Heidari Farid, Talebi Elham, Taleghani Maryam Rezakhani, Maserat Neda, Forutan Maryam, Ghorbani Raheb, Gharehdaghi Jaber, Shirkoohi Reza, Raoofian Reza
Primary Institution: Legal Medicine Research Center, Legal Medicine Organization, Tehran, Iran
Hypothesis
The study investigates the association of GSTT1 and GSTM1 gene polymorphisms with addiction to morphine and methamphetamine in the Iranian population.
Conclusion
The GSTM1 gene may be involved in the development of morphine addiction, but further studies are needed to confirm these findings.
Supporting Evidence
- A significant association was found between GSTM1 polymorphisms and morphine addiction.
- The odds ratio for morphine addiction in relation to GSTM1 was 2.15.
- No significant association was found between GSTT1 polymorphisms and addiction.
Takeaway
This study looked at how certain genes might affect people's chances of becoming addicted to drugs like morphine and methamphetamine.
Methodology
Blood and urine samples were collected from 50 opium users, 30 methamphetamine users, and 80 healthy controls, and analyzed for drug presence and genetic polymorphisms using PCR and chromatography techniques.
Potential Biases
Selection bias may be present due to the retrospective nature of the study.
Limitations
The study had a small sample size, potential confounding variables were not reported, and it was retrospective in nature.
Participant Demographics
Participants were male, aged 18-65, of Iranian origin.
Statistical Information
P-Value
0.03
Confidence Interval
1.05 to 4.39
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website